Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from the non‐genetically modified Aspergillus niger strain AE‐GN Authors: EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L M Solano, Henk Van Loveren, Laurence Vernis, Cristina Andreoli, Andrea Terron, Daniele Cavanna, Natalia Kovalkovicova, Jaime Aguilera, Magdalena Andryszkiewicz, Rita Ferreira de Sousa, Yi Liu Published: 2026 ABSTRACT AbstractThe food enzyme glucan 1,4‐α‐glucosidase (4‐α‐d‐glucan α‐glucohydrolase; EC 3.2.1.3) is produced with the non‐genetically modified Aspergillus niger strain AE‐GN by Amano Enzyme Inc. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in 13 food manufacturing processes. Since residual amounts of food enzyme–Total Organic Solids (TOS) are removed in two processes, dietary exposure was calculated for the remaining 11 food manufacturing processes. It was estimated to be up to 1.739 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1002 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 576. A search for the homology of the amino acid sequence of the glucan 1,4‐α‐glucosidase to known allergens was made and two matches with respiratory allergens were found. The Panel considered that a risk of allergic reactions upon dietary exposure cannot be excluded, but that the likelihood is low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.Keywords: Aspergillus niger; EC 3.2.1.3; EFSA‐Q‐2023‐00223; food enzyme; glucan‐1,4‐α‐glucosidase; glucoamylase; non‐genetically modified microorganism INTRODUCTION Article 3 of the Regulation (EC) No 1332/2008 1 provides a definition for ‘food enzyme’ and ‘food enzyme preparation’. ‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products thereof including a product obtained by a fermentation process using microorganisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods. ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution. Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 2 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed; it does not pose a safety concern to the health of the consumer at the level of use proposed; there is a reasonable technological need; there is a reasonable technological need; its use does not mislead the consumer. its use does not mislead the consumer. All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Background and Terms of Reference as provided by the requestor Background as provided by the European Commission Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/20081 on food enzymes. Five applications have been introduced by the company “Amano Enzyme Inc.” and the Association of Manufacturers and Formulators of Enzyme Products (AMFEP) for the authorisation of the food enzymes Ribonuclease P from Penicillium citrinum (strain AE‐RP), Glutaminase from Bacillus amyloliquefaciens (strain AE‐GT); Oryzin from Aspergillus melleus (strain AE‐P); Triacylglycerol lipase from Candida rugosa (strain AE‐LAY) and Glucoamylase from Aspergillus niger respectively. Following the requirements of Article 12.1 of Regulation (EC) No 234/2011 3 implementing Regulation (EC) No 1331/2008,2 the Commission has verified that the six applications fall within the scope of the food enzyme Regulation and contains all the elements required under Chapter II of that Regulation. Terms of Reference The European Commission requests the European Food Safety Authority to carry out the safety assessments on the food enzymes Ribonuclease P from Penicillium citrinum (strain AE‐RP), Glutaminase from Bacillus amyloliquefaciens (strain AE‐GT); Oryzin from Aspergillus melleus (strain AE‐P); Triacylglycerol lipase from Candida rugosa (strain AE‐LAY) and Glucoamylase from Aspergillus niger in accordance with Article 17.3 of Regulation (EC) No 1332/20081 on food enzymes. Interpretation of the Terms of Reference The present scientific opinion addresses the European Commission's request to carry out the safety assessment of food enzyme Glucoamylase from Aspergillus niger submitted by AMFEP. The application was submitted initially as a joint dossier 4 and identified as the EFSA‐Q‐2015‐00292. During a meeting between EFSA, the European Commission and AMFEP, 5 it was agreed that joint dossiers will be split into individual data packages. The current opinion addresses one data package originating from the joint dossier. This data package is identified as EFSA‐Q‐2023‐00223 and concerns the food enzyme glucan 1,4‐α‐glucosidase produced with the Aspergillus niger strain AE‐GN and was submitted by Amano Enzyme Inc. DATA AND METHODOLOGIES Data The applicant has submitted a dossier in support of the application for authorisation of the food enzyme glucan 1,4‐α‐glucosidase from a non‐genetically modified Aspergillus niger AE‐GN. Additional information, requested from the applicant during the assessment process on 25 March 2024 and 21 April 2026, was received on 23 April 2024 and 24 April 2026, respectively (see ‘Documentation provided to EFSA’). Methodologies The assessment was conducted in line with the principles described in the EFSA ‘Guidance on transparency in the scientific aspects of risk assessment’ (EFSA, 2009a) and following the relevant guidance documents of the EFSA Scientific Committee. The ‘Guidance on the submission of a dossier on food enzymes for safety evaluation’ (EFSA, 2009b) as well as the ‘Statement on characterisation of microorganisms used for the production of food enzymes’ (EFSA CEP Panel, 2019) have been followed for the evaluation of the application. Additional information was requested in accordance with the updated ‘Scientific Guidance for the submission of dossiers on food enzymes’ (EFSA CEP Panel, 2021) and the guidance on the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). ASSESSMENT IUBMB nomenclatureGlucan 1,4‐α‐glucosidaseSystematic name4‐α‐d‐glucan glucohydrolaseSynonymsglucoamylase; amyloglucosidase; exo‐1,4‐α‐glucosidaseIUBMB NoEC 3.2.1.3CAS No9032‐08‐0EINECS No232‐877‐2 Glucan 1,4‐α‐glucosidases catalyse the hydrolytic release of terminal α‐1,4‐linked D‐glucose residues successively from the non‐reducing ends of amylose and amylopectin. The food enzyme under assessment is intended to be used in 13 food manufacturing processes as defined in the EFSA guidance (EFSA CEP Panel, 2023): processing of cereals and other grains for the production of (1) baked products, (2) cereal‐based products other than baked, (3) brewed products, (4) glucose syrups and other starch hydrolysates, (5) distilled alcohol and (6) non‐wine vinegar; processing of fruits and vegetables for the production of (7) juices, (8) fruit and vegetable products other than juices and (9) alcoholic beverages other than grape wine; processing of plant‐ and fungal‐derived products for the production of (10) coffee extracts, (11) tea and other herbal and fruit infusions, (12) plant extracts and (13) plant‐based analogues of milk and milk products. Source of the food enzyme The glucan 1,4‐α‐glucosidase is produced with the non‐genetically modified filamentous fungus Aspergillus niger strain AE‐GN, which is deposited at the National Institute of Technology and Evaluation (NITE) Biological Resource Center (Japan) with the deposition number ■■■■■. 6 The production strain was identified as A. niger by ■■■■■ 7 The production strain A. niger AE‐GN was derived from the parental strain ■■■■■. 8 Production of the food enzyme The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/2004, 9 with food safety procedures based on Hazard Analysis and Critical Control Points and in accordance with good manufacturing practice. 10 The production strain is grown as a pure culture using a typical industrial medium in a ■■■■■ fermentation system with conventional process controls in place. To facilitate glucan 1,4‐α‐glucosidase production, an α‐amylase (EFSA FEZ Panel, 2024) is added during fermentation to liquefy starch present in the fermentation medium. After completion of the fermentation, the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is further purified and concentrated, including an ultrafiltration step in which enzyme protein is retained, while most of the low molecular mass material passes the membrane and is discarded. The applicant provided information on the identity of the substances used to control the fermentation and in the subsequent downstream processing of the food enzyme. 11 , 12 The Panel considered that sufficient information has been provided on the manufacturing process and the quality assurance system implemented by the applicant to exclude issues of concern. Characteristics of the food enzyme Properties of the food enzyme The glucan 1,4‐α‐glucosidase is composed of ■■■■■ amino acids 13 and the molecular mass of the mature protein, calculated from the amino acid sequence, is ■■■■■ kDa. 14 The food enzyme was analysed by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis. 15 A consistent protein pattern was observed across all batches. The gel showed a major protein band corresponding to an apparent molecular mass of about ■■■■■ kDa, consistent with the expected mass of the enzyme. No other enzyme activities were reported. 16 The determination of glucan 1,4‐α‐glucosidase activity is based on the hydrolysis of starch (reaction conditions: ■■■■■). The release of glucose was measured by means of a coupled enzymatic reaction detected spectrophotometrically at 505 nm. The enzyme activity is expressed in Unit/g. One unit is defined as the amount of enzyme that releases 1 mg of glucose in 60 min under the assay conditions. 17 The food enzyme has a temperature optimum around 65°C (■■■■■) and a pH optimum around 4.5 (■■■■■). Thermostability was tested by pre‐incubation of the food enzyme for 1 h at different temperatures (■■■■■). Enzyme activity decreased above 40°C, showing no residual activity at 80°C. 18 Chemical parameters Data were provided for three batches of the food enzyme intended for commercialisation and one batch produced for the toxicological tests (Table 1). 19 The mean Total Organic Solids (TOS) of the three batches intended for commercialisation was 94.6% and the mean enzyme activity/TOS ratio was 453 Unit/mg TOS. TABLE 1Composition of the food enzyme.ParametersUnitBatches1234 a Glucan 1,4‐α‐glucosidase activity Unit/g b 436,000435,000413,000431,000 Protein %73.472.972.473.1 Ash %0.10.10.10.1 Water %5.15.65.34.5 Total organic solids (TOS) c %94.894.394.695.4 Glucan 1,4‐α‐glucosidase/TOS ratio Unit/mg TOS460461437452 a Batch used for the toxicological studies. b Unit: Glucan 1,4‐α‐glucosidase activity (see Section 3.3.1). c TOS calculated as 100% – % water – % ash. Composition of the food enzyme. Batch used for the toxicological studies. Unit: Glucan 1,4‐α‐glucosidase activity (see Section 3.3.1). TOS calculated as 100% – % water – % ash. Purity The lead content in all the batches was below 1 mg/kg 20 , 21 which complies with the specification for lead as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). The food enzyme complies with the microbiological criteria for total coliforms, Escherichia coli and Salmonella, as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). 22 No antimicrobial activity was detected in any of the tested batches. 23 Strains of Aspergillus species, in common with most filamentous fungi, have the capacity to produce a range of secondary metabolites (Frisvad et al., 2018). The presence of aflatoxins (B1, B2, G1, G2), ochratoxin A, fumonisins (B1, B2), T2‐toxin, HT2‐toxin, zearalenone and sterigmatocystin was examined in the three food enzyme batches intended for commercialisation. All were below the limits of quantification (LoQs) of the applied methods. 24 , 25 , 26 Adverse effects caused by the possible presence of other secondary metabolites are addressed by the toxicological examination of the food enzyme. The Panel considered that the information provided on the purity of the food enzyme was sufficient. Viable cells of the production strain The absence of viable cells of the production strain in the food enzyme was demonstrated in three independent batches analysed in triplicate. ■■■■■. No colonies were detected. A positive control was included. 27 Toxicological data A battery of toxicological tests including a bacterial reverse mutation test (Ames test), an in vitro mammalian cell micronucleus test and a repeated dose 90‐day oral toxicity study in rats has been provided. The batch 4 (Table 1), used in these studies, has a similar protein pattern and enzyme activity/TOS ratio to the batches intended for commercialisation and thus is considered suitable as a test item. Genotoxicity Bacterial reverse mutation test A bacterial reverse mutation test (Ames test) was performed according to the Organisation for Economic Co‐operation and Development (OECD) Test Guideline 471 (OECD, 2020) and following good laboratory practice (GLP). 28 Four strains of Salmonella Typhimurium (TA98, TA100, TA1535 and TA1537) and Escherichia coli WP2uvrA were used with or without metabolic activation (S9‐mix), applying the pre‐incubation method. The main experiments were carried out in triplicate, using five concentrations of the food enzyme of 313, 625, 1250, 2500 and 5000 μg TOS/plate. No cytotoxicity was observed at any concentration of the test substance. Upon treatment with the food enzyme, there was no biologically relevant increase in the number of revertant colonies above the control values, in any strain tested, with or without S9‐mix. The Panel concluded that the food enzyme did not induce gene mutations under the test conditions applied in this study. In vitro mammalian cell micronucleus test The in vitro mammalian cell micronucleus test was carried out according to OECD Test Guideline 487 (OECD, 2016) and following GLP. 29 An experiment was performed with duplicate cultures of human lymphoblastoid TK6 cells. The cell cultures were treated with the food enzyme with or without metabolic activation (S9‐mix). On the basis of the results of a range‐finding test, in the main experiment, cells were exposed to the food enzyme and scored for the frequency of mononucleated cells with micronuclei at concentrations of 1250, 2500 and 5000 μg TOS/mL in a short‐term treatment (4‐h exposure and 20‐h recovery period) either with or without S9‐mix and in a long‐term treatment (24‐h exposure without recovery period) without S9‐mix. No cytotoxicity was seen either in the short‐term treatment with and without S9‐mix or in the long‐term treatment. The frequency of micronucleated cells was not statistically significantly different to the negative controls at any concentration tested. The Panel concluded that the food enzyme did not induce an increase in the frequency of micronucleated cells under the test conditions applied in this study. Repeated dose 90‐day oral toxicity study in rodents The repeated dose 90‐day oral toxicity study was performed under GLP and according to the OECD Test Guideline 408 (OECD, 2018). 30 Groups of 10 male and 10 female Sprague–Dawley (Crl:CD(SD)) rats received the food enzyme by gavage in doses of 250, 501 and 1002 mg TOS/kg bw per day. Controls received the vehicle (water for injection). No mortality was observed. In the detailed clinical observations, in week 1, a statistically significant increase in rearing count was observed in low‐ and high‐dose males (+67% both). The Panel considered the change as not toxicologically relevant, as it was only recorded at a single time interval, it was only observed in one sex and there was no dose–response relationship. Haematological investigations revealed a statistically significant decrease in mean corpuscular haemoglobin (MCH) in mid‐dose females (−3%). The Panel considered the change as not toxicologically relevant, as it was only observed in one sex, there was no dose–response relationship, the change was small and there were no changes in other relevant parameters (other red blood cell parameters). Clinical chemistry investigations revealed a statistically significant increase in albumin (Alb) in mid‐dose females (+8%). The Panel considered the change as not toxicologically relevant, as it was only observed in one sex, there was no dose–response relationship, there were no changes in other relevant parameters (globulin, A/G ratio) and there were no histopathological changes in liver and kidneys. Statistically significant changes detected in organ weights were an increase in the absolute lung weight in high‐dose females (+7%) and a decrease in the relative spleen weight in mid‐dose females (−11%). The Panel considered the changes as not toxicologically relevant, as they were only observed in one sex (both parameters), there was no dose–response relationship (relative spleen weight), the change was small (spleen) and there were no histopathological changes in lungs and spleen. No toxicologically relevant or other statistically significant differences to controls were reported. The Panel identified a no observed adverse effect level (NOAEL) of 1002 mg TOS/kg bw per day, the highest dose tested. Allergenicity The allergenicity assessment considered only the food enzyme and not additives, carriers or other excipients that may be used in the final formulation. The potential allergenicity of the glucan 1,4‐α‐glucosidase produced with Aspergillus niger strain AE‐GN was assessed by comparing its amino acid sequence with those of known allergens as described in the EFSA GMO Scientific Opinion (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino acids as the criterion, matches with two respiratory allergens were found using the AllergenOnline and Allermatch databases. 31 The matching allergens were a glucoamylase (77.5% sequence identity) from Arthroderma benhamiae and Sch c 1 (67.5% sequence identity), a glucoamylase from Schizophyllum commune. No reports on oral or respiratory sensitisation or elicitation reactions of the food enzyme under assessment have been published. 32 Sch c 1, the glucoamylase from S. commune is known as an occupational respiratory allergen associated with baker's asthma (Toyotome et al., 2014). The glucoamylase from Arthroderma benhamiae is a putative respiratory allergen with sequence homology to Sch c 1. Several studies have shown that individuals respiratorily sensitised to a food enzyme are usually able to ingest the corresponding enzyme without acquiring clinical symptoms of food allergy (Armentia et al., 2009; Cullinan et al., 1997; Poulsen, 2004). In addition, no allergic reactions upon dietary exposure to any glucan 1,4‐α‐glucosidase have been reported in the literature. The Panel considered that the results of the sequence homology search and the available literature do not indicate a risk of allergic reactions upon dietary exposure to the food enzyme under assessment. The production strain belongs to the Aspergillus genus, which is known to cause respiratory allergy (Kurup et al., 2000; Shen & Han, 1998; Vermani et al., 2015). Allergic reactions after oral exposure have been reported, but are rare (Xing et al., 2022). The biomass is removed during the production process; however, allergenic proteins of the production strain can be released into the culture medium from which the food enzyme is obtained. ■■■■■ ■■■■■ and ■■■■■, known sources of allergens, are present in the medium. During the fermentation process, these products will mostly be degraded and utilised by the production strain. Taken together, concerning the potential allergic reactions due to the production strain and the raw material in the culture medium, the Panel considered that residual amounts of allergenic proteins could be present in the food enzyme. Taking into account the level of dietary exposure (see Section 3.5), this would result in minute amounts in the final foods, from which allergic reactions are usually not expected. In conclusion, when used for the production of distilled alcohol, the Panel considered that a risk of allergic reactions upon dietary exposure can be excluded. For the remaining intended uses, the risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, but the likelihood is low. Dietary exposure Intended use of the food enzyme The food enzyme is intended to be used in 13 food manufacturing processes at the recommended use levels summarised in Table 2. TABLE 2Intended uses and recommended use levels of the food enzyme as provided by the applicant. 33 , 34 Food manufacturing process a Raw material (RM)Maximum recommended use level (mg TOS/kg RM) b Processing of cereals and other grains Production of baked products Flour 34.6 Production of cereal‐based products other than baked Cereals, flour 69.2 Production of brewed products Cereals 6.9 Production of glucose syrups and other starch hydrolysates Starch2906.9 35 Production of distilled alcohol Cereals2768.5 Production of non‐wine vinegar Cereals 69.2 Processing of fruits and vegetables Production of juices Fruits and vegetables 34.6 Production of fruit and vegetable products other than juices Fruits and vegetables 34.6 Production of alcoholic beverages other than grape wine Fruits and vegetables 34.6 Processing of plant‐ and fungal‐derived products Production of coffee extracts Coffee beans 346.1 Production of tea and other herbal and fruit infusions Leaf extract (herb, tea), leaf extract rich in glucosylated steviol glycoside 69.2 Production of plant extracts Plant extract 69.2 Production of plant‐based analogues of milk and milk products Cereals, pulses, legumes, oil seeds, nuts, etc. 69.2 a The name has been harmonised by EFSA according to the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). b The numbers in bold were used for calculation. Intended uses and recommended use levels of the food enzyme as provided by the applicant. 33 , 34 Production of baked products Production of baked products Production of cereal‐based products other than baked Production of cereal‐based products other than baked Production of brewed products Production of brewed products Production of glucose syrups and other starch hydrolysates Production of glucose syrups and other starch hydrolysates Production of distilled alcohol Production of distilled alcohol Production of non‐wine vinegar Production of non‐wine vinegar Production of juices Production of juices Production of fruit and vegetable products other than juices Production of fruit and vegetable products other than juices Production of alcoholic beverages other than grape wine Production of alcoholic beverages other than grape wine Production of coffee extracts Production of coffee extracts Production of tea and other herbal and fruit infusions Production of tea and other herbal and fruit infusions Production of plant extracts Production of plant extracts Production of plant‐based analogues of milk and milk products Production of plant‐based analogues of milk and milk products The name has been harmonised by EFSA according to the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). The numbers in bold were used for calculation. The glucan 1,4‐α‐glucosidase catalyses the hydrolysis of starch in a variety of raw materials to release glucose. It is used to increase the amount of fermentable sugars or to enhance sweetness. In the production of baked products and cereal‐based products other than baked, the food enzyme is added to flour during the preparation of the dough or batter. 36 The food enzyme–TOS remain in the final foods. In the production of beer, the food enzyme is added to cereals during the mashing. 37 For the production of fermented beverages like sake or rice wine, it may be added during the slurry mixing, the liquefaction, the fermentation or the saccharification. 38 The food enzyme–TOS remain in the brewed products. In the production of glucose syrups and other starch hydrolysates, the food enzyme is added to starch during the saccharification. 39 The Panel considers that the food enzyme–TOS are removed from glucose syrups and other starch hydrolysates (EFSA CEP Panel, 2023). In the production of distilled alcohol, the food enzyme is added to cereals during the saccharification and fermentation. 40 The food enzyme–TOS are not carried over into the distilled alcohols (EFSA CEP Panel, 2023). In the production of non‐wine vinegar, the food enzyme may be added to cereals during slurry mixing, liquefaction, saccharification and fermentation. 41 The food enzyme–TOS remain in the non‐wine vinegars. In the production of juices, the food enzyme is added to raw juices after the depectinisation. 42 The food enzyme–TOS remain in the final juices. In the production of fruit and vegetable products other than juices, the food enzyme is added after the mash treatment. 43 The food enzyme–TOS remain in the final foods. In the production of alcoholic beverages other than grape wine, the food enzyme may be added to the mashed fruits or directly to the juice before fermentation. 44 The food enzyme–TOS remain in the final products. In the production of coffee extracts, the food enzyme is added to the ground coffee beans. 45 The glucan 1,4‐α‐glucosidase acts in combination with galactomannan degrading enzymes. The latter degrade the polysaccharides to oligosaccharides, on which the glucan 1,4‐α‐glucosidase can exert its activity. The hydrolysis catalysed by this food enzyme contributes to the reduction of turbidity and improves the filtration rate. 46 , 47 The food enzyme–TOS remain in the coffee extracts. In the production of tea and other herbal and fruit infusions, the glucan 1,4‐α‐glucosidase is added to the leaf extracts from Stevia. 48 The food enzyme–TOS remain in the final foods. In the treatment of plant extracts, the food enzyme is added to the plant extracts (vanilla, rosemary, paprika etc.) before the filtration. 49 The food enzyme–TOS remain in the final foods. In the production of plant‐based analogues of milk and milk products, the food enzyme may be added to cereals 50 , 51 or to the raw plant‐based beverages. 52 The food enzyme–TOS remain in the final products. Based on data provided on thermostability (see Section 3.3.1) and the downstream processing within the respective food manufacturing processes, the Panel considered that the food enzyme is inactivated in most of the food manufacturing processes listed in Table 2 in which the food enzyme–TOS remain. However, it may remain in its active form in baked products, in juices and in non‐wine vinegars, depending on the heat treatment conditions. Dietary exposure estimation In accordance with the guidance document (EFSA CEP Panel, 2021), a dietary exposure was calculated for the 11 food manufacturing processes where the food enzyme–TOS remain in the final foods. Chronic exposure to the food enzyme–TOS was calculated by combining the maximum recommended use level with individual consumption data (EFSA CEP Panel, 2021). The estimation involved the selection of relevant food categories and the application of technical conversion factors (EFSA CEP Panel, 2023). Table 3 provides an overview of the derived exposure estimates across all surveys. Detailed mean and 95th percentile exposure to the food enzyme–TOS per age class, country and survey, as well as contribution from each FoodEx category to the total dietary exposure are reported in Appendix A – Tables 1 and 2. For the present assessment, food consumption data were available from 48 dietary surveys (covering infants, toddlers, children, adolescents, adults and the elderly), carried out in 26 European countries (Appendix B). The highest dietary exposure was estimated to be 1.739 mg TOS/kg bw per day in children at the 95th percentile. TABLE 3Summary of the estimated dietary exposure to food enzyme–TOS in six population groups.Population groupEstimated exposure (mg TOS/kg body weight per day)InfantsToddlersChildrenAdolescentsAdultsThe elderly Age range 3–11 months12–35 months3–9 years10–17 years18–64 years≥ 65 years Min–max mean (number of surveys)0.097–0.543 (12)0.302–1.258 (15)0.222–0.673 (19)0.146–0.467 (21)0.130–0.382 (22)0.081–0.355 (23) Min–max 95th percentile (number of surveys)0.262–1.284 (11)0.793–1.722 (14)0.447–1.739 (19)0.310–1.085 (20)0.274–0.901 (22)0.183–0.687 (22) Summary of the estimated dietary exposure to food enzyme–TOS in six population groups. Uncertainty analysis In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and are summarised in Table 4. TABLE 4Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate.Sources of uncertaintiesDirection of impact Model input data Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard+/−Use of data from food consumption surveys of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)+Possible national differences in categorisation and classification of food+/− Model assumptions and factors Exposure to food enzyme–TOS always calculated based on the recommended maximum use level+Selection of broad FoodEx categories for the exposure assessment+Use of recipe fractions to disaggregate FoodEx categories+/−Use of technical factors in the exposure model+/−Exclusion of two processes from the exposure estimation:−– Production of glucose syrups and other starch hydrolysates– Production of distilled alcohol Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate. Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. The conservative approach applied to estimate the dietary exposure to the food enzyme–TOS, in particular assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to an overestimation of the exposure. The exclusion of two food manufacturing processes from the exposure estimation was based on > 99% of TOS removal. This is not expected to impact the overall estimate derived. Margin of exposure A comparison of the NOAEL (1002 mg TOS/kg bw per day) identified from the 90‐day rat study with the derived exposure estimates of 0.081–1.258 mg TOS/kg bw per day at the mean and from 0.183 to 1.739 mg TOS/kg bw per day at the 95th percentile resulted in a margin of exposure of at least 576. CONCLUSIONS Based on the data provided and the derived margin of exposure, the Panel concluded that the food enzyme glucan 1,4‐α‐glucosidase produced with the non‐genetically modified Aspergillus niger strain AE‐GN does not give rise to safety concerns under the intended conditions of use. DOCUMENTATION AS PROVIDED TO EFSA Application for authorisation of glucan 1,4‐α‐glucosidase from Aspergillus niger AE‐GN. March 2023. Submitted by Amano Enzyme Inc. Additional information. April 2024. Submitted by Amano Enzyme Inc. Additional information. April 2026. Submitted by Amano Enzyme Inc. ABBREVIATIONS body weight Chemical Abstracts Service EFSA Panel on Food Contact Materials, Enzymes and Processing Aids colony forming units European Commission European Inventory of Existing Commercial Chemical Substances European Union Food and Agricultural Organization of the United Nations Good Laboratory Practice genetically modified organism International Union of Biochemistry and Molecular Biology Joint FAO/WHO Expert Committee on Food Additives kiloDalton limit of detection mean corpuscular haemoglobin Organisation for Economic Cooperation and Development Total Organic Solids World Health Organization REQUESTOR European Commission QUESTION NUMBER EFSA‐Q‐2023‐00223 COPYRIGHT FOR NON‐EFSA CONTENT EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source. PANEL MEMBERS José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize de Lourdes Marzo Solano, Henk Van Loveren, Laurence Vernis and Holger Zorn. LEGAL NOTICE The full opinion will be published in accordance with Article 12 of Regulation (EC) No 1331/2008 once the decision on confidentiality will be received from the European Commission. Supporting information APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details ACKNOWLEDGEMENTS The Panel wishes to thank the following for the support provided to this scientific output: Andew Chesson, Pier Sandro Cocconcelli, Francesco Pesce and Eleonora Marini. Dietary exposure estimates to the food enzyme–TOS in details Appendix A can be found in the online version of this output (in the ‘Supporting information’ section). The file contains two sheets, corresponding to two tables. Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey. Table 2: Contribution of food categories to the dietary exposure to the food enzyme–TOS per age class, country and survey. Population groups considered for the exposure assessment PopulationAge rangeCountries with food consumption surveys covering more than 1 day Infants From 12 weeks on up to and including 11 months of ageBulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Portugal, Slovenia, Spain Toddlers From 12 months up to and including 35 months of ageBelgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Netherlands, Portugal, Republic of North Macedonia*, Serbia*, Slovenia, Spain Children From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Netherlands, Portugal, Republic of North Macedonia*, Serbia*, Spain, Sweden Adolescents From 10 years up to and including 17 years of ageAustria, Belgium, Bosnia and Herzegovina*, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden Adults From 18 years up to and including 64 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden The elderly a From 65 years of age and olderAustria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden*Consumption data from these pre‐accession countries are not reported in Table 3 of this opinion; however, they are included in Appendix B for testing purpose. a The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). Consumption data from these pre‐accession countries are not reported in Table 3 of this opinion; however, they are included in Appendix B for testing purpose. The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). EFSA FEZ Panel (EFSA Panel on Food Enzymes) , Zorn, H. , Barat Baviera, J. M. , Bolognesi, C. , Catania, F. , Gadermaier, G. , Greiner, R. , Mayo, B. , Mortensen, A. , Roos, Y. H. , Solano, M. L. M. , Van Loveren, H. , Vernis, L. , Andreoli, C. , Terron, A. , Cavanna, D. , Kovalkovicova, N. , Aguilera, J. , Andryszkiewicz, M. , de Sousa, R. F. , & Liu, Y. (2026). Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from the non‐genetically modified Aspergillus niger strain AE‐GN . EFSA Journal, 24(6), e10131. 10.2903/j.efsa.2026.10131 Adopted: 20 May 2026 Correspondence: Ask a Question The declarations of interest of all scientific experts active in EFSA's work are available at https://open.efsa.europa.eu/experts. Notes Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, pp. 7–15. Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, pp. 1–6. Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 64, 11.03.2011, pp. 15–24. Commission Implementing Regulation (EU) No 562/2012 of 27 June 2012 amending Commission Regulation (EU) No 234/2011 with regard to specific data required for risk assessment of food enzymes Text with EEA relevance. OJ L 168, 28.6.2012, p. 21–23. The full detail is available at the https://www.efsa.europa.eu/en/events/event/ad‐hoc‐meeting‐industry‐association‐amfep‐joint‐dossiers‐food‐enzymes. Additional information April 24/Annex 1. Technical dossier/Annex 5. Technical dossier/p. 39. Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs. OJ L 226, 25.6.2004, pp. 3–21. Technical dossier/pp. 43–44/Annex 6‐1/Annex 6–2. Technical dossier/p. 44–45/Annex 8. Additional information April 2024/ Answer to question 3. Technical dossier/p. 35/Annex 13. Technical dossier/p. 35. Technical dossier/p. 34. Technical dossier/pp. 8, 36. Technical dossier/Annex 2. Technical dossier/p. 37. Technical dossier/pp. 33, 70 & Annex 3, Annex 12 p. 32, Annex 11 p. 26, Annex 10 p. 25. LoD: Pb: 0.01 mg/kg. Technical dossier/Annex 3 and Additional information April 2024/Annex 3. Technical dossier/Annexes 1 and 3. Technical dossier/Annexes 1 and 3. LoQs: aflatoxins: B1, B2, G1 and G2 = 0.2 μg/kg each; ochratoxin A = 0.5 μg/kg; fumonisins B1 and B2 = 5.0 μg/kg each; T2‐toxin, HT2‐toxin, zearalenone, sterigmatocystin = 10.0 μg/kg each. Technical dossier/Annex 1/Annex 3. Additional information April 2024/ Answer to question 5. Additional information April 2024/Annex 2. Technical dossier/Annex 10. Technical dossier/Annex 11. Technical dossier/Annex 12. Technical dossier/pp. 70–73/Annex 13. Additional information April 2024/Annex 4. Technical dossier/pp. 60–61. Additional information April 26. Additional information April 26. Technical dossier/Annex 9/pp. 1, 5, 6. Technical dossier/Annex 9/p. 2. Technical dossier/Annex 9/p. 3. Technical dossier/Annex 9/p. 7. Technical dossier/Annex 9/p. 8. Technical dossier/Annex 9/p. 4. Technical dossier/Annex 9/p. 10. Technical dossier/Annex 9/p. 10. Technical dossier/Annex 9/p. 11. Technical dossier/Annex 9/pp. 13–14. Technical dossier/p. 59. Technical dossier/ Patent ‐ JP4995145B2 ‐ Production method of coffee extract. Technical dossier/Annex 9/p. 9. Technical dossier/Annex 9/p. 9. Technical dossier/Annex 9/p. 6. Additional information April 26. Technical dossier/Annex 9/p. 12. REFERENCES Associated Data Supplementary Materials APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details